Viewing Study NCT05735834


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-27 @ 10:54 PM
Study NCT ID: NCT05735834
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module